Experts from Spain and Japan join forces in La Rioja to unravel the language of carbohydrates

Researchers from CIC bioGUNE participated in the I Glycoforo La Rioja-Hokkaido-Euskadi, organized by the University of La Rioja.

The event, held on September 7th and 8th, brought together experts in chemical biomedicine from Spain and Japan to address the importance of carbohydrates in cellular communication and in the identification of targets for viruses.

CIC bioGUNE, member of BRTA, participated in the I Glycoforo La Rioja-Hokkaido-Euskadi, a highly relevant event organized by the University of La Rioja. This symposium, held on September 7th and 8th, brought together distinguished experts in chemical biomedicine from Spain and Japan with the slogan "Decoding the Language of Carbohydrates".

The first day of the congress took place in Logroño, specifically in the conference room of Bodegas Campo Viejo, and focused on addressing the most relevant aspects related to carbohydrates, their "code" and their implications in biomedicine. The next day, the event moved to the headquarters of the Language Institute in San Millán de la Cogolla, where the historical importance of La Rioja and its contribution to Spanish was highlighted.

The congress featured the participation of renowned globally recognized experts in the field of study, such as Professor Nishimura and Professor Hinou, from Hokkaido University, Dr. Francisco Corzana, Principal Investigator of the Glycopeptide4life group from the University of La Rioja and Jesús Jiménez-Barbero, scientific director of CIC bioGUNE and Professor Ikerbasque.

This symposium brought together leading scientists in the field of 'glycoscience' with the aim of establishing a forum for knowledge exchange, learning and collaboration on joint scientific projects. The main objective was to unravel the mysteries behind cellular communication and viral target identification, highlighting the critical importance of carbohydrates in this fundamental process.

The I Glycoforo La Rioja-Hokkaido-Euskadi marked a milestone in the exploration of the secrets of carbohydrates and further strengthened the scientific collaboration between Spain and Japan in this critical area.

For more information, visit the following link.

About CIC bioGUNE

The Centre for Cooperative Research in Biosciences (CIC bioGUNE), member of the Basque Research & Technology Alliance (BRTA), located in the Bizkaia Technology Park, is a biomedical research organisation conducting cutting-edge research at the interface between structural, molecular and cell biology, with a particular focus on generating knowledge on the molecular bases of disease, for use in the development of new diagnostic methods and advanced therapies.

About BRTA

BRTA is an alliance of 4 collaborative research centres (CIC bioGUNE, CIC nanoGUNE, CIC biomaGUNE y CIC energiGUNE) and 12 technology centres (Azterlan, Azti, Ceit, Cidetec, Gaiker, Ideko, Ikerlan, Lortek, Neiker, Tecnalia, Tekniker and Vicomtech) with the main objective of developing advanced technological solutions for the Basque corporate fabric.

With the support of the Basque Government, the SPRI Group and the Provincial Councils of the three territories, the alliance seeks to promote collaboration between the research centres, strengthen the conditions to generate and transfer knowledge to companies, contributing to their competitiveness and outspreading the Basque scientific-technological capacity abroad.

BRTA has a workforce of 3,500 professionals, executes 22% of the Basque Country's R&D investment, registers an annual turnover of more than 300 million euros and generates 100 European and international patents per year.

Spanish version

See a large version of the first picture


CIC bioGUNE hosts the presentation of BRTA's personalized health research agenda

The presentation event of the personalized health research agenda, organized by the Basque...



International collaboration teams up for innovative omics technologies integration workshop

Researchers from CIC bioGUNE in collaboration with researchers from NOVA Medical...